Technological assessment of intracytoplasmic sperm injection: an analysis of the value context

Since the introduction of intracytoplasmic sperm injection (ICSI) in 1992, the new technology has raised a series of basic moral issues. In this article, I present a brief review of this moral debate. I argue that even if we solve the moral problems of the debate, there is a residue of value issues. These value issues are crucial for the understanding of the dynamics of the health policy and the legislative process concerning ICSI. That is, values analyses are crucial to make viable moral judgments about new technologies such as ICSI.